Project Details
The role of cross presentation in viral infection
Applicant
Professor Dr. Thomas Brocker
Subject Area
Immunology
Term
from 2010 to 2014
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 179593469
“Cross-presentation” describes the presentation of exogenous antigen via MHC class I to CD8 T cells. This mechanism explains how inactivation of self-reactive CD8 T cells by tolerance induction to self-antigen might occur. In addition, cross-presentation seems to allow the generation of cytotoxic T cell responses to exogenous tumour antigens or antigens derived from virus, which can inactivate infected Dendritic Cells and inhibit direct MHC I presentation. Although several cell types seem to be able to cross-present antigens, Dendritic Cells are most potent to do so. However, despite many efforts, the contribution of cross-presentation to control of viral infections and vaccination is still unclear. Using a combination of transgenic mice with dendritic cells unable to crosspresent exogenous antigens and Herpes-Simplex-Virus- as well as Murine Cytomegalovirus-mutants lacking genes contributing to immune inactivation, we will study the role of cross-presentation in primary and memory CD8 T cell responses. The outcome of this study will be relevant for the basic understanding of the functioning of the immune system, as well as the rational design of vaccines.
DFG Programme
Research Grants